Tripuraneni Radhika — SEC Form 4 filings
SEC reporting owner CIK 1761114. 9 Form 4 filings on record with FilingPulse; latest filed 2026-08-18.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-06-14 to 2026-08-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Terns Pharmaceuticals, Inc. (TERN) | Director | 6 | — | — | 12 |
| Viridian Therapeutics, Inc.\DE (VRDN) | Chief Medical Officer | 3 | — | — | 5 |
Form 4 filings — Tripuraneni Radhika
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) | Option exercise (M): 40,000 @ $13.21 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2026-05-05 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Disposition to issuer (D): 64,000 (derivative) · Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 10,657 (derivative) · Disposition to issuer (D): 4,676 (derivative) · Disposition to issuer (D): 32,000 (derivative) · Disposition to issuer (D): 32,000 (derivative) · +1 more | EDGAR |
| 2026-03-04 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/award (A): 95,800 (derivative) @ $0 · Grant/award (A): 19,150 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 1,697 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2025-03-12 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/award (A): 310,700 (derivative) @ $0 | EDGAR |
| 2025-02-03 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 10,657 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 4,676 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 32,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1761114 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →